| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1031790039 |
| P356 | DOI | 10.1186/GM546 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1186/gm546 |
| P932 | PMC publication ID | 4062063 |
| P698 | PubMed publication ID | 24944580 |
| P5875 | ResearchGate publication ID | 263291569 |
| P50 | author | Joanne Doherty | Q57969839 |
| P2093 | author name string | Michael J Owen | |
| P2860 | cites work | ADHD, major depressive disorder, and simple phobias are prevalent psychiatric conditions in youth with velocardiofacial syndrome. | Q51942553 |
| Cognitive performance in schizophrenia patients assessed before and following the first psychotic episode. | Q51945465 | ||
| Clinical findings in 33 subjects with large supernumerary marker(15) chromosomes and 3 subjects with triplication of 15q11-q13. | Q53637126 | ||
| Diagnostic exome sequencing in persons with severe intellectual disability | Q55670486 | ||
| Examining the Comorbidity Between Attention Deficit Hyperactivity Disorder and Bipolar I Disorder: A Meta-Analysis of Family Genetic Studies | Q57399796 | ||
| Increased exonic de novo mutation rate in individuals with schizophrenia | Q59667688 | ||
| A Family Study of Schizoaffective, Bipolar I, Bipolar II, Unipolar, and Normal Control Probands | Q63869312 | ||
| Continuity and discontinuity of affective disorders and schizophrenia. Results of a controlled family study | Q72545950 | ||
| Investigation of NRXN1 deletions: clinical and molecular characterization | Q86393147 | ||
| Advanced paternal age is associated with impaired neurocognitive outcomes during infancy and childhood | Q21144644 | ||
| A systematic review of the prevalence of schizophrenia | Q21144720 | ||
| The Kraepelinian dichotomy - going, going... but still not gone | Q22241683 | ||
| The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis | Q22241865 | ||
| What causes attention deficit hyperactivity disorder? | Q22242209 | ||
| Rare chromosomal deletions and duplications increase risk of schizophrenia | Q22337245 | ||
| Functional impact of global rare copy number variation in autism spectrum disorders | Q24596191 | ||
| Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis | Q24597718 | ||
| The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia | Q24619976 | ||
| Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder | Q24627620 | ||
| Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation | Q24629022 | ||
| Microduplications of 16p11.2 are associated with schizophrenia | Q24634151 | ||
| Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder | Q24634497 | ||
| Disruption of neurexin 1 associated with autism spectrum disorder | Q24643899 | ||
| Disruption of the neurexin 1 gene is associated with schizophrenia | Q24647095 | ||
| Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities | Q24647145 | ||
| Neurexin 1 (NRXN1) deletions in schizophrenia | Q24649863 | ||
| Large recurrent microdeletions associated with schizophrenia | Q24654741 | ||
| Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder | Q24655630 | ||
| A twin study of genetic relationships between psychotic symptoms | Q28211685 | ||
| Prevalence of autism-spectrum conditions: UK school-based population study | Q28246681 | ||
| Genome-wide association study identifies five new schizophrenia loci | Q28248384 | ||
| Common polygenic variation contributes to risk of schizophrenia and bipolar disorder | Q28250609 | ||
| Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP) | Q28252295 | ||
| Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia | Q28256580 | ||
| Advancing paternal age and autism | Q28261936 | ||
| Association between microdeletion and microduplication at 16p11.2 and autism | Q28264205 | ||
| Patterns and rates of exonic de novo mutations in autism spectrum disorders | Q28264242 | ||
| Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia | Q28274064 | ||
| Microdeletion 15q13.3: a locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders. | Q37419604 | ||
| Psychopathology and cognition in children with 22q11.2 deletion syndrome | Q37424826 | ||
| Risk of mental illness in offspring of parents with schizophrenia, bipolar disorder, and major depressive disorder: a meta-analysis of family high-risk studies | Q37451503 | ||
| Analysis of copy number variations at 15 schizophrenia-associated loci. | Q37541157 | ||
| Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder | Q37571848 | ||
| High frequencies of de novo CNVs in bipolar disorder and schizophrenia | Q37578876 | ||
| The role of DNA copy number variation in schizophrenia. | Q37595947 | ||
| Genome-wide association analysis of copy number variation in recurrent depressive disorder. | Q37611740 | ||
| Molecular genetic evidence for overlap between general cognitive ability and risk for schizophrenia: a report from the Cognitive Genomics consorTium (COGENT). | Q37670805 | ||
| Genetic relationships between schizophrenia, bipolar disorder, and schizoaffective disorder | Q37699386 | ||
| Molecular and clinical characterization of 25 individuals with exonic deletions of NRXN1 and comprehensive review of the literature | Q38093545 | ||
| Neurodevelopmental disorders and genetic testing: current approaches and future advances. | Q38115271 | ||
| New ethical issues for genetic counseling in common mental disorders | Q38125112 | ||
| Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. | Q38133045 | ||
| Learning disabilities and executive dysfunction in boys with attention-deficit/hyperactivity disorder | Q38437146 | ||
| Genomics and the classification of mental illness: focus on broader categories | Q39325276 | ||
| A controlled family study of chronic psychoses. Schizophrenia and schizoaffective disorder | Q39709714 | ||
| Toward new approaches to psychotic disorders: the NIMH Research Domain Criteria project | Q42399695 | ||
| The internet is parents' main source of information about psychiatric manifestations of 22q11.2 deletion syndrome (22q11.2DS). | Q42556773 | ||
| Autism symptoms in Attention-Deficit/Hyperactivity Disorder: a familial trait which correlates with conduct, oppositional defiant, language and motor disorders | Q42662785 | ||
| Impaired intellect and memory: a missing link between genetic risk and schizophrenia? | Q42674378 | ||
| Psychiatry, the pharmaceutical industry, and the road to better therapeutics | Q43233120 | ||
| Polygenic risk for schizophrenia is associated with cognitive change between childhood and old age. | Q44592961 | ||
| Association between schizophrenia and common variation in neurocan (NCAN), a genetic risk factor for bipolar disorder | Q45075170 | ||
| The Roscommon Family Study. IV. Affective illness, anxiety disorders, and alcoholism in relatives | Q45090793 | ||
| Genetics of autism: overview and new directions | Q45107766 | ||
| Maternal and paternal age and risk of autism spectrum disorders. | Q45936043 | ||
| The symptoms of autism spectrum disorders in adolescence and adulthood | Q47274092 | ||
| Autistic spectrum disorders in velo-cardio facial syndrome (22q11.2 deletion). | Q48332601 | ||
| Specificity of psychosis, mania and major depression in a contemporary family study. | Q48413890 | ||
| IQ and risk for schizophrenia: a population-based cohort study. | Q48582691 | ||
| Sustained attention deficit in bipolar disorder. | Q48643730 | ||
| Intellectual disability and major psychiatric disorders: a continuum of neurodevelopmental causality. | Q48704419 | ||
| Relationship between clinical and neuropsychological characteristics in child and adolescent first degree relatives of subjects with schizophrenia. | Q49018246 | ||
| No evidence that common genetic risk variation is shared between schizophrenia and autism. | Q50303685 | ||
| Reduced burden of very large and rare CNVs in bipolar affective disorder. | Q50309743 | ||
| Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay. | Q50312488 | ||
| Nine patients with a microdeletion 15q11.2 between breakpoints 1 and 2 of the Prader-Willi critical region, possibly associated with behavioural disturbances. | Q50341061 | ||
| The Research Domain Criteria: moving the goalposts to change the game. | Q50656914 | ||
| 15q11.2 microdeletion - seven new patients with delayed development and/or behavioural problems. | Q51822786 | ||
| Neurocognitive endophenotypes in a multiplex multigenerational family study of schizophrenia. | Q51904034 | ||
| Childhood antecedent disorders to bipolar disorder in adults: a controlled study. | Q51930938 | ||
| Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study | Q28275978 | ||
| Strong association of de novo copy number mutations with sporadic schizophrenia | Q28282047 | ||
| Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample | Q28288117 | ||
| Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities | Q28296227 | ||
| Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs | Q28296286 | ||
| Genome-wide association analysis identifies 13 new risk loci for schizophrenia | Q28297287 | ||
| Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications | Q28304430 | ||
| The worldwide prevalence of ADHD: a systematic review and metaregression analysis | Q28304626 | ||
| Multiple Recurrent De Novo CNVs, Including Duplications of the 7q11.23 Williams Syndrome Region, Are Strongly Associated with Autism | Q29013643 | ||
| CNVs conferring risk of autism or schizophrenia affect cognition in controls | Q29308426 | ||
| Rare De Novo and Transmitted Copy-Number Variation in Autistic Spectrum Disorders | Q29394511 | ||
| De Novo Gene Disruptions in Children on the Autistic Spectrum | Q29394534 | ||
| Identification of loci associated with schizophrenia by genome-wide association and follow-up | Q29417130 | ||
| Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4 | Q29417143 | ||
| Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size | Q29544005 | ||
| GCTA: a tool for genome-wide complex trait analysis | Q29547216 | ||
| De novo mutations revealed by whole-exome sequencing are strongly associated with autism | Q29547269 | ||
| Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations | Q29614573 | ||
| A copy number variation morbidity map of developmental delay | Q29616033 | ||
| Exome sequencing supports a de novo mutational paradigm for schizophrenia. | Q30405748 | ||
| Using large clinical data sets to infer pathogenicity for rare copy number variants in autism cohorts | Q30572502 | ||
| De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. | Q33398247 | ||
| Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia | Q33662873 | ||
| Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia | Q33740241 | ||
| Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders | Q33874840 | ||
| Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. | Q33992163 | ||
| Schizophrenia: an integrated sociodevelopmental-cognitive model | Q34023115 | ||
| Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative | Q34026000 | ||
| Microdeletions of 3q29 confer high risk for schizophrenia | Q34050937 | ||
| A polygenic burden of rare disruptive mutations in schizophrenia | Q34060200 | ||
| Identifying loci for the overlap between attention-deficit/hyperactivity disorder and autism spectrum disorder using a genome-wide QTL linkage approach | Q34089144 | ||
| Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis | Q34247422 | ||
| Estimating the proportion of variation in susceptibility to schizophrenia captured by common SNPs. | Q34255285 | ||
| Family history of schizophrenia and bipolar disorder as risk factors for autism | Q34295552 | ||
| A 15q13.3 microdeletion segregating with autism | Q34326191 | ||
| Using summary data from the danish national registers to estimate heritabilities for schizophrenia, bipolar disorder, and major depressive disorder | Q34333039 | ||
| Changes in prevalence of parent-reported autism spectrum disorder in school-aged U.S. children: 2007 to 2011-2012. | Q34427570 | ||
| The penetrance of copy number variations for schizophrenia and developmental delay. | Q34497136 | ||
| De novo mutations in schizophrenia implicate synaptic networks | Q34540372 | ||
| A review of the evidence from family, twin and adoption studies for a genetic contribution to adult psychiatric disorders | Q34561361 | ||
| Family, twin, and adoption studies of bipolar disease | Q34577196 | ||
| Advanced parental age and the risk of autism spectrum disorder | Q34599167 | ||
| Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative | Q34734906 | ||
| Analysis of genetic deletions and duplications in the University College London bipolar disorder case control sample | Q34873753 | ||
| Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype | Q34902898 | ||
| Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study | Q34923924 | ||
| Meta-analytic evidence for familial coaggregation of schizophrenia and bipolar disorder. | Q34990933 | ||
| Copy number variation in schizophrenia in the Japanese population | Q35010699 | ||
| Childhood developmental abnormalities in schizophrenia: evidence from high-risk studies | Q35068141 | ||
| Cognitive decline in schizophrenia from childhood to midlife: a 33-year longitudinal birth cohort study | Q35252525 | ||
| Rare copy number variants: a point of rarity in genetic risk for bipolar disorder and schizophrenia | Q35764622 | ||
| Copy number variations of chromosome 16p13.1 region associated with schizophrenia | Q35900760 | ||
| Evidence for a fragile X mental retardation protein-mediated translational switch in metabotropic glutamate receptor-triggered Arc translation and long-term depression. | Q35949697 | ||
| Children with 7q11.23 Duplication Syndrome: Speech, Language, Cognitive, and Behavioral Characteristics and their Implications for Intervention | Q36059777 | ||
| Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcome | Q36091184 | ||
| Maternally derived microduplications at 15q11-q13: implication of imprinted genes in psychotic illness | Q36193455 | ||
| Synapse proteomics of multiprotein complexes: en route from genes to nervous system diseases. | Q36252737 | ||
| A 600 kb deletion syndrome at 16p11.2 leads to energy imbalance and neuropsychiatric disorders | Q36386207 | ||
| 22q11.2 deletion syndrome: attitudes towards disclosing the risk of psychiatric illness | Q36431058 | ||
| Schizophrenia genetic variants are not associated with intelligence | Q36551460 | ||
| Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3. | Q36695755 | ||
| Attention-deficit hyperactivity disorder symptoms in a clinic sample of children and adolescents with pervasive developmental disorders | Q36698562 | ||
| Risk of bipolar disorder and schizophrenia in relatives of people with attention-deficit hyperactivity disorder | Q37061214 | ||
| Shared polygenic contribution between childhood attention-deficit hyperactivity disorder and adult schizophrenia | Q37061218 | ||
| Support for the involvement of large copy number variants in the pathogenesis of schizophrenia | Q37147142 | ||
| Mortality, ADHD, and psychosocial adversity in adults with childhood ADHD: a prospective study | Q37290084 | ||
| Singleton deletions throughout the genome increase risk of bipolar disorder | Q37326513 | ||
| Reciprocal duplication of the Williams-Beuren syndrome deletion on chromosome 7q11.23 is associated with schizophrenia | Q37337299 | ||
| Evidence that duplications of 22q11.2 protect against schizophrenia | Q37414526 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 29 | |
| P577 | publication date | 2014-04-28 | |
| P1433 | published in | Genome Medicine | Q15816848 |
| P1476 | title | Genomic insights into the overlap between psychiatric disorders: implications for research and clinical practice | |
| P478 | volume | 6 |
| Q47276840 | A Genome-Wide Association Study and Complex Network Identify Four Core Hub Genes in Bipolar Disorder |
| Q35802831 | A cross-species genetic analysis identifies candidate genes for mouse anxiety and human bipolar disorder |
| Q61849574 | A genome-wide association study of shared risk across psychiatric disorders implicates gene regulation during fetal neurodevelopment |
| Q38757268 | A genome-wide quantitative trait locus (QTL) linkage scan of NEO personality factors in Latino families segregating bipolar disorder |
| Q37739910 | ASD and schizophrenia show distinct developmental profiles in common genetic overlap with population-based social communication difficulties |
| Q37696565 | Addressing reverse inference in psychiatric neuroimaging: Meta-analyses of task-related brain activation in common mental disorders |
| Q50345507 | Adult autism spectrum as a transnosographic dimension. |
| Q38759421 | Altering the course of schizophrenia: progress and perspectives |
| Q37310541 | Animal Models of Maternal Immune Activation in Depression Research |
| Q37005185 | Association of Genetic Risk for Schizophrenia With Nonparticipation Over Time in a Population-Based Cohort Study |
| Q90781341 | Attention-deficit hyperactivity disorder shares copy number variant risk with schizophrenia and autism spectrum disorder |
| Q35620380 | Autism beyond diagnostic categories: characterization of autistic phenotypes in schizophrenia |
| Q91831376 | Autistic Traits and Illness Trajectories |
| Q91774669 | Brain gray matter network organization in psychotic disorders |
| Q47552092 | Comorbid autism spectrum disorder and anxiety disorders: a brief review |
| Q35988422 | Comparison of visual perceptual organization in schizophrenia and body dysmorphic disorder |
| Q40128202 | Converging evidence for an impact of a functional NOS gene variation on anxiety-related processes. |
| Q35246537 | Copy number variants encompassing Mendelian disease genes in a large multigenerational family segregating bipolar disorder |
| Q64228579 | Cytochrome P450 2C19 Poor Metabolizer Phenotype in Treatment Resistant Depression: Treatment and Diagnostic Implications |
| Q61801094 | Dynamic expression of genes associated with schizophrenia and bipolar disorder across development |
| Q47913477 | Effects of common GRM5 genetic variants on cognition, hippocampal volume and mGluR5 protein levels in schizophrenia. |
| Q38681930 | Epigenetics of Autism Spectrum Disorder |
| Q91892352 | Exome sequencing identifies de novo splicing variant in XRCC6 in sporadic case of autism |
| Q35990042 | FXR1P is a GSK3β substrate regulating mood and emotion processing |
| Q99353130 | Familial coaggregation of major psychiatric disorders in first-degree relatives of individuals with autism spectrum disorder: a nationwide population-based study |
| Q40418374 | Fine-mapping of antipsychotic response genome-wide association studies reveals novel regulatory mechanisms |
| Q28071570 | From Asperger's Autistischen Psychopathen to DSM-5 Autism Spectrum Disorder and Beyond: A Subthreshold Autism Spectrum Model |
| Q47552479 | Gene regulatory mechanisms underlying sex differences in brain development and psychiatric disease. |
| Q100737121 | Genetic association of FMRP targets with psychiatric disorders |
| Q39424410 | Genetics of Schizophrenia: Overview of Methods, Findings and Limitations |
| Q91770400 | Genotype-phenotype associations in children with copy number variants associated with high neuropsychiatric risk in the UK (IMAGINE-ID): a case-control cohort study |
| Q37223293 | Immune signatures and disorder-specific patterns in a cross-disorder gene expression analysis |
| Q39130188 | Modeling neurodevelopmental and psychiatric diseases with human iPSCs |
| Q38679839 | Modeling psychiatric disorders with patient-derived iPSCs |
| Q100736965 | Mutations associated with neuropsychiatric conditions delineate functional brain connectivity dimensions contributing to autism and schizophrenia |
| Q31114703 | Negative affect predicts social functioning across schizophrenia and bipolar disorder: Findings from an integrated data analysis |
| Q38917986 | Neurodevelopmental Perspectives on Wnt Signaling in Psychiatry |
| Q30844089 | New statistical approaches exploit the polygenic architecture of schizophrenia--implications for the underlying neurobiology |
| Q35737901 | Novel genetic advances in schizophrenia: an interview with Michael O'Donovan |
| Q52884385 | Overlapping 16p13.11 deletion and gain of copies variations associated with childhood onset psychosis include genes with mechanistic implications for autism associated pathways: Two case reports. |
| Q42286241 | Patient-derived hiPSC neurons with heterozygous CNTNAP2 deletions display altered neuronal gene expression and network activity |
| Q42361493 | Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry |
| Q36972791 | Prefrontal neuronal integrity predicts symptoms and cognition in schizophrenia and is sensitive to genetic heterogeneity |
| Q48342101 | Prenatal testing for neuropsychiatric disorders. |
| Q39145749 | Proteomic analysis of the postsynaptic density implicates synaptic function and energy pathways in bipolar disorder |
| Q60915706 | Protocol for a transdiagnostic study of children with problems of attention, learning and memory (CALM) |
| Q26744368 | Recent Advances in Autism Spectrum Disorders: Applications of Whole Exome Sequencing Technology |
| Q48901423 | Review: changing (shared) heritability of ASD and ADHD across the lifespan. |
| Q30377846 | Risk Factors Associated With Language in Autism Spectrum Disorder: Clues to Underlying Mechanisms. |
| Q41658777 | Schizophrenia and the neurodevelopmental continuum:evidence from genomics |
| Q34447169 | Schizophrenia genetics: emerging themes for a complex disorder. |
| Q92432772 | Shared vulnerability for connectome alterations across psychiatric and neurological brain disorders |
| Q31150357 | Structural brain imaging correlates of ASD and ADHD across the lifespan: a hypothesis-generating review on developmental ASD-ADHD subtypes |
| Q36424672 | Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders |
| Q40183800 | Systems genetics identifies a convergent gene network for cognition and neurodevelopmental disease |
| Q59052397 | The Concept of Schizophrenia: From Unity to Diversity |
| Q48164870 | The association of proopiomelanocortin polymorphisms with the risk of major depressive disorder and the response to antidepressants via interactions with stressful life events |
| Q58657746 | The ethics of patenting autism genes |
| Q38802467 | The promises and challenges of human brain organoids as models of neuropsychiatric disease |
| Q24288977 | Top 10 Replicated Findings From Behavioral Genetics |
| Q91199127 | Transcriptomic networks implicate neuronal energetic abnormalities in three mouse models harboring autism and schizophrenia-associated mutations |
| Q89984725 | Ubiquitous neurocognitive dysfunction in familial adenomatous polyposis: proof-of-concept of the role of APC protein in neurocognitive function |
| Q57403235 | Use of schizophrenia and bipolar disorder polygenic risk scores to identify psychotic disorders |
| Q42544634 | What can we learn from the high rates of schizophrenia in people with 22q11.2 deletion syndrome? |
Search more.